Cognitive function in Chinese prostate cancer patients on androgen-deprivation therapy: A cross-sectional study

Asia-Pacific Journal of Clinical Oncology

Volumn 11, Issue 4, 2015, Pages 277-281

  Yang, Jing ^a   Zhong, Fei ^a   Qiu, Ju ^a   Wang, Kai ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Androgen deprivation therapy; Cognition; Cross sectional study; Prostate cancer

Indexed keywords

AGE DISTRIBUTION; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; ATTENTION; CHINESE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; COGNITION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EDUCATIONAL STATUS; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MEMORY CONSOLIDATION; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; PROSTATE CANCER; SCORING SYSTEM; STROOP TEST; TRAILMAKING B; TREATMENT RESPONSE; WAIS DIGIT SPAN FORWARD; ASIAN CONTINENTAL ANCESTRY GROUP; CANCER STAGING; CASE CONTROL STUDY; CHEMICALLY INDUCED; CHINA; COGNITION DISORDERS; COMPLICATION; PREVALENCE; PROGNOSIS; PROSTATIC NEOPLASMS; PSYCHOLOGY;

ANTIANDROGEN;

AGED; ANDROGEN ANTAGONISTS; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; HUMANS; MALE; NEOPLASM STAGING; NEUROPSYCHOLOGICAL TESTS; PREVALENCE; PROGNOSIS; PROSTATIC NEOPLASMS;

EID: 84945463362     PISSN: 17437555     EISSN: 17437563     Source Type: Journal    
DOI: 10.1111/ajco.12347     Document Type: Article

References (24)

1. Cullen J, Elsamanoudi S, Brassell SA etal. The burden of prostate cancer in Asian nations. J Carcinog 2012; 11: 7.
2. Shahinian VB, Kuo YF, Freeman JL, Orihuela E, Goodwin JS. Increasing use of gonadotropin-releasing hormone agonists for the treatment of localized prostate carcinoma. Cancer 2005; 103: 1615-1624.
3. Barrass BJ, Thurairaja R, Persad RA. More should be done to prevent the harmful effects of long-term androgen ablation therapy in prostate cancer. BJU Int 2004; 93: 1175-1176.
4. Sharpley CF, Christie DR, Bitsika V. Do hormone treatments for prostate cancer cause anxiety and depression? Int J Clin Oncol 2014; 19: 523-530.
5. Moore AR, O'Keeffe ST. Drug-induced cognitive impairment in the elderly. Drugs Aging 1999; 15: 15-28.
6. Almeida OP, Waterreus A, Spry N, Flicker L, Martins RN. One year follow-up study of the association between chemical castration, sex hormones, beta-amyloid, memory and depression in men. Psychoneuroendocrinology 2004; 29: 1071-1081.
7. Green HJ, Pakenham KI, Headley BC etal. Altered cognitive function in men treated for prostate cancer with luteinizing hormone-releasing hormone analogues and cyproterone acetate: a randomized controlled trial. BJU Int 2002; 90: 427-432.
8. Jenkins VA, Bloomfield DJ, Shilling VM, Edginton TL. Does neoadjuvant hormone therapy for early prostate cancer affect cognition? Results from a pilot study. BJU Int 2005; 96: 48-53.
9. Joly F, Alibhai SM, Galica J etal. Impact of androgen deprivation therapy on physical and cognitive function, as well as quality of life of patients with nonmetastatic prostate cancer. J Urol 2006; 176: 2443-2447.
10. Alibhai SM, Breunis H, Timilshina N etal. Impact of androgen-deprivation therapy on cognitive function in men with nonmetastatic prostate cancer. J Clin Oncol 2010; 28: 5030-5037.
11. Salminen E, Portin R, Korpela J etal. Androgen deprivation and cognition in prostate cancer. Br J Cancer 2003; 89: 971-976.
12. Jamadar RJ, Winters MJ, Maki PM. Cognitive changes associated with ADT: a review of the literature. Asian J Androl 2012; 14: 232-238.
13. Chambers SK, Hyde MK, Ip DF, Dunn JC, Gardiner RA. Systematic review of research into the psychological aspects of prostate cancer in Asia: what do we know? Asian Pac J Cancer Prev 2013; 14: 2621-2626.
14. Cherrier MM, Aubin S, Higano CS. Cognitive and mood changes in men undergoing intermittent combined androgen blockade for non-metastatic prostate cancer. Psychooncology 2009; 18: 237-247.
15. Chen X, Zhu C, Li J etal. Dissociation of decision making under ambiguity and decision making under risk in breast cancer patients receiving adjuvant chemotherapy: a neuropsychological study. Brain Res 2013; 1533: 63-72.
16. Strauss E, Sherman EMS, Spreen OA. Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. Oxford University Press, New York 2006.
17. Wechsler D. Wechsler Adult Intelligence Scale-III. Psychological Corp, San Antonio, TX 1997.
18. Stroop J. Studies of interference in serial verbal reactions. J Exp Psychol 1935; 18: 643-662.
19. Klove H. Clinical neuropsychology. Med Clin North Am 1963; 47: 1647-1658.
20. Nasreddine Z. Montreal Cognitive Assessment Beijing Version, 2006.
21. Lezak MD. Neuropsychological assessment in behavioral toxicology-developing techniques and interpretative issues. Scand J Work Environ Health 1984; 10: 25-29.
22. Chao HH, Uchio E, Zhang S etal. Effects of androgen deprivation on brain function in prostate cancer patients - a prospective observational cohort analysis. BMC Cancer 2012; 12: 371.
23. Chao HH, Hu S, Ide JS etal. Effects of androgen deprivation on cerebral morphometry in prostate cancer patients-an exploratory study. PLoS ONE 2013; 8: e72032.
24. Green HJ, Pakenham KI, Headley BC etal. Quality of life compared during pharmacological treatments and clinical monitoring for non-localized prostate cancer: a randomized controlled trial. BJU Int 2004; 93: 975-979.